Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes
- PMID: 24835211
- PMCID: PMC4024041
- DOI: 10.1371/journal.pone.0097060
Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes
Abstract
Chronic activation of innate immunity takes place in obesity and initiated by the hypertrophic adipocytes which obtain a pro-inflammatory phenotype. The corticotrophin-releasing factor (CRF) family of neuropeptides and their receptors (CRF1 and CRF2) affect stress response and innate immunity. Adipose tissue expresses a complete CRF system. The aim of this study was to examine the role of CRF neuropeptides in the immune phenotype of adipocytes assessed by their expression of the toll-like receptor-4 (TLR4), the production of inflammatory cytokines IL-6, TNF-α and IL-1β, chemokines IL-8, monocyte attractant protein-1 (MCP-1) and of the adipokines adiponectin, resistin and leptin. Our data are as follows: (a) CRF, UCN2 and UCN3 are expressed in human white adipocytes as well as CRFR1a, CRFR2a and CRFR2b but not CRFR2c. 3T3L1 pre-adipocytes and differentiated adipocytes expressed both CRF1 and CRF2 receptors and UCN3, while UCN2 was detected only in differentiated adipocytes. CRF2 was up-regulated in mouse mature adipocytes. (b) CRF1 agonists suppressed media- and LPS-induced pre-adipocyte differentiation while CRF2 receptor agonists had no effect. (c) In mouse pre-adipocytes, CRF2 agonists suppressed TLR4 expression and the production of IL-6, CXCL1 and adiponectin while CRF1 agonists had no effect. (d) In mature mouse adipocytes LPS induced IL-6 and CXCL1 production and suppressed leptin. (e) In human visceral adipocytes LPS induced IL-6, TNF-α, IL-8, MCP-1 and leptin production and suppressed adiponectin and resistin. (f) In mouse mature adipocytes CRF1 and CRF2 agonists suppressed basal and LPS-induced production of inflammatory cytokines, TLR4 expression and adiponectin production, while in human visceral adipocytes CRF and UCN1 suppressed basal and LPS-induced IL-6, TNF-α, IL-8 and MCP-1 production. In conclusion, the effects of the activation of CRF1 and CRF2 may be significant in ameliorating the pro-inflammatory activity of adipocytes in obesity.
Conflict of interest statement
Figures








Similar articles
-
The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.Int J Obes (Lond). 2015 Mar;39(3):408-17. doi: 10.1038/ijo.2014.164. Epub 2014 Sep 5. Int J Obes (Lond). 2015. PMID: 25189177
-
The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.Neuropeptides. 2021 Aug;88:102147. doi: 10.1016/j.npep.2021.102147. Epub 2021 Apr 20. Neuropeptides. 2021. PMID: 33932861
-
Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.J Cell Physiol. 2007 Mar;210(3):774-83. doi: 10.1002/jcp.20900. J Cell Physiol. 2007. PMID: 17117478
-
The peripheral corticotropin releasing factor family's role in vasculitis.Vascul Pharmacol. 2024 Mar;154:107275. doi: 10.1016/j.vph.2023.107275. Epub 2024 Jan 4. Vascul Pharmacol. 2024. PMID: 38184094 Review.
-
Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.J Gastroenterol. 2015 Aug;50(8):819-30. doi: 10.1007/s00535-015-1086-8. Epub 2015 May 12. J Gastroenterol. 2015. PMID: 25962711 Review.
Cited by
-
Urocortin Neuropeptide Levels Are Impaired in the PBMCs of Overweight Children.Nutrients. 2022 Jan 18;14(3):429. doi: 10.3390/nu14030429. Nutrients. 2022. PMID: 35276788 Free PMC article.
-
Evidence from NHANES 2011-2014: a correlation between the weight-adjusted-waist index and cognitive abilities in the United States.Front Aging Neurosci. 2025 Jan 30;17:1480609. doi: 10.3389/fnagi.2025.1480609. eCollection 2025. Front Aging Neurosci. 2025. PMID: 39949539 Free PMC article.
-
Circulating levels of urocortin neuropeptides are impaired in children with overweight.Obesity (Silver Spring). 2022 Feb;30(2):472-481. doi: 10.1002/oby.23356. Obesity (Silver Spring). 2022. PMID: 35088550 Free PMC article.
-
Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) promote adipocyte differentiation and inhibit inflammation in 3T3-F442A cells.PLoS One. 2015 Feb 25;10(2):e0117492. doi: 10.1371/journal.pone.0117492. eCollection 2015. PLoS One. 2015. PMID: 25714093 Free PMC article.
-
Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.Clin Exp Metastasis. 2015 Apr;32(4):353-68. doi: 10.1007/s10585-015-9714-5. Epub 2015 Mar 24. Clin Exp Metastasis. 2015. PMID: 25802102 Free PMC article.
References
-
- Tsatsanis C, Androulidaki A, Alissafi T, Charalampopoulos I, Dermitzaki E, et al. (2006) Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J Immunol 176: 1869–1877. - PubMed
-
- Tsatsanis C, Androulidaki A, Dermitzaki E, Gravanis A, Margioris AN (2007) Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-αlpha release from macrophages via induction of COX-2 and PGE2. J Cell Physiol 210: 774–783. - PubMed
-
- Charalampopoulos I, Androulidaki A, Minas V, Chatzaki E, Tsatsanis C, et al. (2006) Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells. Neuroendocrinology 84: 49–57. - PubMed
-
- Tsatsanis C, Androulidaki A, Dermitzaki E, Charalampopoulos I, Spiess J, et al. (2005) Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2. FEBS Lett 579: 4259–4264. - PubMed
-
- Trayhurn P, Wood IS (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33: 1078–1081. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous